Ceftolozane-tazobactam was non-inferior to levofloxacin for composite cure ( @ -LSB- @ % -RSB- of @ vs @ -LSB- @ % -RSB- of @ , @ % CI @-@ ) and , as the lower bound of the two-sided @ % CI around the treatment difference was positive and greater than zero , superiority was indicated .